Document:

<PAGE>

                                                                    EXHIBIT 10.2

                                  $175,000,000

                                AGCO CORPORATION

              1.75% CONVERTIBLE SENIOR SUBORDINATED NOTES DUE 2033

                               PURCHASE AGREEMENT

<PAGE>

                                                December 17, 2003

Morgan Stanley & Co. Incorporated
Rabo Securities USA, Inc.
c/o Morgan Stanley & Co. Incorporated
      1585 Broadway
      New York, New York 10036

Dear Sirs and Mesdames:

         AGCO Corporation, a Delaware corporation (the "COMPANY"), proposes to
issue and sell to the several purchasers named in Schedule I hereto (the
"INITIAL PURCHASERS") $175,000,000 principal amount of its 1.75% Convertible
Senior Subordinated Notes due 2033 (the "FIRM SECURITIES") to be issued pursuant
to the provisions of an Indenture (the "INDENTURE") to be entered into between
the Company and SunTrust Bank, as Trustee (the "TRUSTEE"). The Company also
proposes to issue and sell to the Initial Purchasers not more than an additional
$26,250,000 principal amount of its 1.75% Convertible Senior Subordinated Notes
due 2033 (the "ADDITIONAL SECURITIES") if and to the extent that you, as Manager
of the offering, shall have determined to exercise, on behalf of the Initial
Purchasers, the right to purchase such 1.75% Convertible Senior Subordinated
Notes due 2033 granted to the Initial Purchasers in Section 2 hereof. The Firm
Securities and the Additional Securities are hereinafter collectively referred
to as the "SECURITIES". The Securities will be convertible into shares of common
stock, $0.01 par value, of the Company (the "UNDERLYING SECURITIES").

         The Securities and the Underlying Securities will be offered without
being registered under the Securities Act of 1933, as amended (the "SECURITIES
ACT"), to qualified institutional buyers in compliance with the exemption from
registration provided by Rule 144A under the Securities Act.

         The Initial Purchasers and their direct and indirect transferees will
be entitled to the benefits of a Registration Rights Agreement (the
"REGISTRATION RIGHTS AGREEMENT") to be entered into between the Company and the
Initial Purchasers.

         In connection with the sale of the Securities, the Company has prepared
a preliminary offering memorandum (the "PRELIMINARY MEMORANDUM") and will
prepare a final offering memorandum (the "FINAL MEMORANDUM" and, with the
Preliminary Memorandum, each a "MEMORANDUM") including or incorporating by
reference a description of the terms of the Securities and the Underlying
Securities, the terms of the offering and a description of the Company. As used
herein, the term "Memorandum" shall include in each case the documents
incorporated by reference therein. The terms "SUPPLEMENT", "AMENDMENT" and
"AMEND" as used herein with respect to a Memorandum shall include all documents
deemed to be incorporated by reference in the Preliminary Memorandum or Final
Memorandum that are filed subsequent to the date of

                                       1
<PAGE>

such Memorandum with the Securities and Exchange Commission (the "COMMISSION")
pursuant to the Securities Exchange Act of 1934, as amended (the "EXCHANGE
ACT").

         1. Representations and Warranties. The Company represents and warrants
to, and agrees with, you that:

                  (a)      (i) Each document, if any, filed or to be filed
         pursuant to the Exchange Act and incorporated by reference in either
         Memorandum complied or will comply when so filed in all material
         respects with the Exchange Act and the applicable rules and regulations
         of the Commission thereunder and (ii) the Preliminary Memorandum does
         not contain and the Final Memorandum, on the date of this Agreement and
         on the Closing Date (as defined in Section 4), will not contain any
         untrue statement of a material fact or omit to state a material fact
         necessary to make the statements therein, in the light of the
         circumstances under which they were made, not misleading, except that
         the representations and warranties set forth in this paragraph do not
         apply to statements or omissions in either Memorandum based upon
         information relating to any Initial Purchaser furnished to the Company
         in writing by such Initial Purchaser through you expressly for use
         therein.

                  (b)      The Company has been duly incorporated, is validly
         existing as a corporation in good standing under the laws of the
         jurisdiction of its incorporation, has the corporate power and
         authority to own its property and to conduct its business as described
         in each Memorandum and is duly qualified to transact business and is in
         good standing (to the extent that good standing is a concept recognized
         by such jurisdiction) in each jurisdiction in which the conduct of its
         business or its ownership or leasing of property requires such
         qualification, except to the extent that the failure to be so qualified
         or be in good standing would not have a material adverse effect on the
         Company and its subsidiaries, taken as a whole.

                  (c)      Each subsidiary of the Company has been duly
         incorporated, is validly existing as a corporation in good standing
         under the laws of the jurisdiction of its incorporation, has the
         corporate power and authority to own its property and to conduct its
         business as described in each Memorandum and is duly qualified to
         transact business and is in good standing in each jurisdiction in which
         the conduct of its business or its ownership or leasing of property
         requires such qualification, except to the extent that the failure to
         be so qualified or be in good standing would not have a material
         adverse effect on the Company and its subsidiaries, taken as a whole;
         all of the issued shares of capital stock of each subsidiary of the
         Company have been duly and validly authorized and issued, are fully
         paid and non-assessable and are owned directly by the Company, free and
         clear of all liens, encumbrances, equities or claims.

                                       2
<PAGE>

                  (d)      This Agreement has been duly authorized, executed and
         delivered by the Company.

                  (e)      The authorized capital stock of the Company conforms
         as to legal matters to the description thereof contained in the Final
         Memorandum.

                  (f)      The shares of common stock outstanding prior to the
         issuance of the Securities have been duly authorized and are validly
         issued, fully paid and non-assessable, and there are no authorized or
         outstanding options, warrants or other rights to purchase, or equity or
         debt securities convertible into or exchangeable or exercisable for,
         any shares of common stock of the Company except as described in the
         Final Memorandum.

                  (g)      The Securities have been duly authorized and, when
         executed and authenticated in accordance with the provisions of the
         Indenture and delivered to and paid for by the Initial Purchasers in
         accordance with the terms of this Agreement, will be valid and binding
         obligations of the Company, enforceable in accordance with their terms,
         subject to the effects of applicable bankruptcy, insolvency and similar
         laws affecting creditors' rights generally and general principles of
         equity, and will be entitled to the benefits of the Indenture and the
         Registration Rights Agreement pursuant to which such Securities are to
         be issued.

                  (h)      The Underlying Securities issuable upon conversion of
         the Securities have been duly authorized and reserved and, when issued
         and delivered upon conversion of the Securities in accordance with the
         terms of the Securities, will be validly issued, fully paid and
         non-assessable, and the issuance of the Underlying Securities will not
         be subject to any preemptive or similar rights.

                  (i)      Each of the Indenture and the Registration Rights
         Agreement, as of the Closing Date, will have been duly authorized,
         executed and delivered by, and will be a valid and binding agreement
         of, the Company, enforceable in accordance with its terms, subject to
         applicable bankruptcy, insolvency or similar laws affecting creditors'
         rights generally and general principles of equity and except as rights
         to indemnification and contribution under the Registration Rights
         Agreement may be limited under applicable law.

                  (j)      The execution and delivery by the Company of, and the
         performance by the Company of its obligations under, this Agreement ,
         the Indenture, the Registration Rights Agreement and the Securities
         will not contravene any provision of applicable law or the certificate
         of incorporation or by-laws of the Company, or any agreement or other
         instrument binding upon the Company or any of its subsidiaries that is
         material to the Company and its

                                       3
<PAGE>

         subsidiaries, taken as a whole, or any judgment, order or decree of any
         governmental body, agency or court having jurisdiction over the Company
         or any subsidiary, or result in the creation or imposition of any lien,
         charge or encumbrance upon any assets or property of the Company or any
         of its subsidiaries, and no consent, approval, authorization or order
         of, or qualification with, any governmental body or agency, any lender
         or any other person is required for the performance by the Company of
         its obligations under this Agreement , the Indenture, the Registration
         Rights Agreement or the Securities, except such consents received prior
         to the date hereof and such as may be required by the securities or
         Blue Sky laws of the various states in connection with the offer and
         sale of the Securities and by Federal and state securities laws with
         respect to the Company's obligations under the Registration Rights
         Agreement.

                  (k)      The consolidated financial statements of the Company
         and its subsidiaries, together with related notes and schedules,
         included or incorporated by reference in each Memorandum present
         fairly, in all material respects, the consolidated financial position,
         the results of operations and cash flows of the Company and the
         Subsidiaries, on a consolidated basis, as of the indicated dates and
         for the indicated periods. Such financial statements comply as to form
         in all material respects with the rules of the Commission with respect
         thereto and have been prepared in accordance with generally accepted
         accounting principles in the United States ("GAAP"), consistently
         applied throughout the periods involved, and all adjustments necessary
         for a fair presentation of results for such periods have been made. Any
         pro forma financial information and related notes thereto included in
         each Memorandum present fairly the information shown therein, have been
         prepared in accordance with the Securities Act and the rules of the
         Commission with respect to pro forma financial information, have been
         prepared on a basis consistent with the historical financial statements
         of the Company and have been compiled on the pro forma bases described
         therein, and (A) the assumptions underlying the pro forma adjustments
         are reasonable, (B) such adjustments are appropriate to give effect to
         the transactions or circumstances referred to therein and have been
         properly applied to the historical amounts in the compilation of such
         statements and (C) such statements fairly present the pro forma results
         of operations and information purported to be shown therein for the
         respective periods therein specified based on the assumptions
         identified therein. Except (X) as disclosed in each Memorandum, (Y) as
         reflected in the Company's unaudited balance sheet at September 30,
         2003 or liabilities described in any notes thereto (or liabilities for
         which neither accrual nor footnote disclosure is required pursuant to
         GAAP) or (Z) for liabilities incurred in the ordinary course of
         business since September 30, 2003 consistent with past practice,
         neither the Company nor any subsidiary has any material liabilities or
         obligations of any nature. Except as set forth in each Memorandum,
         neither the Company nor any subsidiary has engaged in or effected any
         transaction or

                                       4
<PAGE>

         arrangement that would constitute an "off-balance sheet arrangement"
         (as defined in Item 303 of Regulation S-K of the Commission). The
         financial information included in each Memorandum included under the
         captions "Summary--AGCO Summary Financial Data," "Capitalization,"
         "Selected Consolidated Financial Data," "Management's Discussion and
         Analysis of Financial Condition and Results of Operations" and
         "Business" (and any amendment or supplement thereto) present fairly in
         accordance with GAAP the information shown therein (except for non-GAAP
         financial measures and ratios which have been presented in compliance
         with Regulation G) and have been compiled on a basis consistent with
         that of the audited and unaudited financial statements from which they
         were derived.

                  (l)      Since the respective dates as of which information is
         given in each Memorandum and exclusive of any amendments or supplements
         thereto subsequent to the date of this Agreement, (i) there has not
         occurred any material adverse change, or any development that might
         reasonably be expected to result in a prospective material adverse
         change, in the condition, financial or otherwise, or in the earnings,
         business operations of the Company and its subsidiaries, taken as a
         whole; (ii) there have been no transactions entered into by the Company
         or any of its subsidiaries, other than those in the ordinary course of
         business, which are material to the Company and its subsidiaries, taken
         as a whole, and (iii) except for regular dividends on the common stock
         of the Company in amounts per share that are consistent with past
         practice, there has been no dividend or distribution of any kind
         declared, paid or made by the Company on any class of its capital
         stock.

                  (m)      There are no legal or governmental proceedings
         pending or, to the knowledge of the Company, threatened, to which the
         Company or any of its subsidiaries is a party or to which any of the
         properties of the Company or any of its subsidiaries is subject other
         than proceedings accurately described in all material respects in each
         Memorandum and proceedings that would not have a material adverse
         effect on the Company and its subsidiaries, taken as a whole, or on the
         power or ability of the Company to perform its obligations under this
         Agreement , the Indenture, the Registration Rights Agreement or the
         Securities or to consummate the transactions contemplated by the Final
         Memorandum.

                  (n)      The Company and its subsidiaries (i) are in
         compliance with any and all applicable foreign, federal, state and
         local laws and regulations relating to the protection of human health
         and safety, the environment or hazardous or toxic substances or wastes,
         pollutants or contaminants ("ENVIRONMENTAL LAWS"), (ii) have received
         all permits, licenses or other approvals required of them under
         applicable Environmental Laws to conduct their respective businesses
         and (iii) are in compliance with all terms and conditions of any such
         permit, license or approval, except where such noncompliance with
         Environmental Laws, failure

                                       5
<PAGE>

         to receive required permits, licenses or other approvals or failure to
         comply with the terms and conditions of such permits, licenses or
         approvals would not, singly or in the aggregate, have a material
         adverse effect on the Company and its subsidiaries, taken as a whole.

                  (o)      To the Company's knowledge, KPMG LLP ("KPMG"),
         independent auditors who have certified certain of the financial
         statements of the Company and its subsidiaries contained in each
         Memorandum, are and were during the periods covered by their reports
         included in each Memorandum independent public accountants within the
         meaning of the Securities Act, Regulation S-X of the Commission and
         Rule 101 of the Code of Professional Ethics of the American Institute
         of Certified Public Accountants. KPMG (i) based solely on
         representations made by KPMG, is, to the Company's knowledge, a
         registered public accounting firm (as defined in Section 2(a)(12) of
         the Sarbanes-Oxley Act of 2002) ("SOX") and (ii) is, with respect to
         the Company, in compliance with subsections (g) through (l) of Section
         10A of the Exchange Act.

                  (p)      The Company and each of its subsidiaries maintain
         disclosure controls and procedures (as defined in Rule 13a-15(e) of the
         Commission) that are designed to ensure that information required to be
         disclosed by the Company in the reports it files or submits under the
         Exchange Act is recorded, processed, summarized and reported within the
         time periods specified in the Commission's rules and forms.

                  (q)      The Company and each of its subsidiaries maintain
         internal control over financial reporting (as defined in Rule 13a-15(f)
         of the Commission) sufficient to provide reasonable assurance regarding
         the (A) reliability of financial reporting and the preparation of
         financial statements for external purposes in accordance with GAAP, (B)
         maintenance of records that in reasonable detail accurately and fairly
         reflect transactions and dispositions of the assets of the Company and
         its subsidiaries, (C) recording of transactions as necessary to permit
         preparation of financial statements in accordance with GAAP and that
         receipts and expenditures of the Company and its subsidiaries are being
         made only in accordance with authorizations of management and directors
         of the Company or the applicable subsidiary, and (D) prevention or
         timely detection of unauthorized acquisition, use or disposition of the
         Company's or its subsidiaries' assets that could have a material effect
         on the financial statements.

                  (r)      The Company's management evaluates, with the
         participation of the Company's principal executive and principal
         financial officers, or persons performing similar functions, (A) the
         effectiveness of the Company's and its

                                       6
<PAGE>

         subsidiaries' disclosure controls and procedures as of the end of each
         fiscal quarter, (B) the Company's and its subsidiaries' internal
         control over financial reporting as of the end of each fiscal year, and
         (C) any change in the Company's or its subsidiaries' internal control
         over financial reporting that occurred during each of the Company's
         fiscal quarters that has materially affected, or is reasonably likely
         to materially affect, the Company's or any subsidiaries' internal
         control over financial reporting.

                  (s)      Except as disclosed in each Memorandum, the Company
         has not, since July 30, 2002, extended or maintained credit, arranged
         for the extension of credit, or renewed an extension of credit, in the
         form of a personal loan to or for any director or executive officer of
         the Company; and any such credit that was outstanding on July 30, 2002
         or that is currently outstanding was in place on or before July 30,
         2002, and there has been no material modification of any term of such
         credit or any renewal or such credit on or after July 30, 2002.

                  (t)      The Company is not, and after giving effect to the
         offering and sale of the Securities and the application of the proceeds
         thereof as described in the Final Memorandum will not be, required to
         register as an "investment company" as such term are defined in the
         Investment Company Act of 1940, as amended.

                  (u)      Neither the Company nor any affiliate (as defined in
         Rule 501(b) of Regulation D under the Securities Act, an "AFFILIATE")
         of the Company has directly, or through any agent, (i) sold, offered
         for sale, solicited offers to buy or otherwise negotiated in respect
         of, any security (as defined in the Securities Act) which is or will be
         integrated with the sale of the Securities in a manner that would
         require the registration under the Securities Act of the Securities or
         (ii) offered, solicited offers to buy or sold the Securities by any
         form of general solicitation or general advertising (as those terms are
         used in Regulation D under the Securities Act) or in any manner
         involving a public offering within the meaning of Section 4(2) of the
         Securities Act.

                  (v)      It is not necessary in connection with the offer,
         sale and delivery of the Securities to the Initial Purchasers in the
         manner contemplated by this Agreement to register the Securities under
         the Securities Act or to qualify the Indenture under the Trust
         Indenture Act of 1939, as amended.

                  (w)      The Securities satisfy the requirements set forth in
         Rule 144A(d)(3) under the Securities Act.

         2. Agreements to Sell and Purchase. The Company hereby agrees to sell
to the several Initial Purchasers, and each Initial Purchaser, upon the basis of
the representations and warranties herein contained, but subject to the
conditions hereinafter stated, agrees, severally and not jointly, to purchase
from the Company the respective

                                       7
<PAGE>

principal amount of the Firm Securities set forth on Schedule I hereto opposite
its name at a purchase price of 100% of the principal amount thereof (the
"PURCHASE PRICE") plus accrued interest, if any, to the Closing Date.

         On the basis of the representations and warranties contained in this
Agreement, and subject to its terms and conditions, the Company agrees to sell
to the Initial Purchasers the Additional Securities, and the Initial Purchasers
shall have the right to purchase, severally and not jointly, up to $26,250,000
of their respective principal amount of Additional Securities at the Purchase
Price plus accrued interest, if any, to the date of payment and delivery. You
may exercise this right on behalf of the Initial Purchasers in whole or from
time to time in part by giving written notice of each election to exercise this
option not later than 30 days after the date of this Agreement. Any exercise
notice shall specify the principal amount of Additional Securities to be
purchased by the Initial Purchasers and the date on which such Additional
Securities are to be purchased. Each purchase date must be at least one business
day after the written notice is given and may not be earlier than the closing
date for the Firm Securities nor later than ten business days after the date of
such notice. Additional Securities may be purchased as provided in Section 4
solely for the purpose of covering over-allotments made in connection with the
offering of the Firm Securities. On each day, if any, that Additional Securities
are to be purchased (an "OPTION CLOSING DATE"), each Initial Purchaser agrees,
severally and not jointly, to purchase the principal amount of Additional
Securities (subject to such adjustments to eliminate fractional Securities as
you may determine) that bears the same proportion to the total principal amount
of Additional Securities to be purchased on such Option Closing Date as the
principal amount of Firm Securities set forth in Schedule I opposite the name of
such Initial Purchaser bears to the total principal amount of Firm Securities.

         The Company hereby agrees that, without the prior written consent of
Morgan Stanley & Co. Incorporated on behalf of the Initial Purchasers, it will
not, during the period ending 90 days after the date of the Final Memorandum,
(i) offer, pledge, sell, contract to sell, sell any option or contract to
purchase, purchase any option or contract to sell, grant any option, right or
warrant to purchase, lend, or otherwise transfer or dispose of, directly or
indirectly, any shares of common stock or any securities convertible into or
exercisable or exchangeable for common stock or (ii) enter into any swap or
other arrangement that transfers to another, in whole or in part, any of the
economic consequences of ownership of the common stock, whether any such
transaction described in clause (i) or (ii) above is to be settled by delivery
of common stock or such other securities, in cash or otherwise. The foregoing
sentence shall not apply to (A) the sale of the Securities under this Agreement,
(B) the contemplated issuance by the Company of approximately $250 million of
common stock in an underwritten public offering as discussed in "Use of
Proceeds" in the Final Memorandum, (C) the issuance by the Company of any shares
of common stock upon the exercise of an option or warrant or the conversion of a
security outstanding on the date hereof of which the Initial Purchaser has been
advised in writing, or (D) the

                                       8
<PAGE>

issuance by the Company of additional options under the Company's existing stock
option plans, provided that such options are not exercisable during the period
ending 90 days after the date of the Final Memorandum.

         3. Terms of Offering. You have advised the Company that the Initial
Purchasers will make an offering of the Securities purchased by the Initial
Purchasers hereunder on the terms to be set forth in the Final Memorandum, as
soon as practicable after this Agreement is entered into as in your judgment is
advisable.

         4. Payment and Delivery. Payment for the Firm Securities shall be made
to the Company in Federal or other funds immediately available in New York City
against delivery of such Firm Securities for the respective accounts of the
several Initial Purchasers at 10:00 a.m., New York City time, on December 23,
2003, or at such other time on the same or such other date, not later than
December 23, 2003, as shall be designated in writing by you. The time and date
of such payment are hereinafter referred to as the "CLOSING DATE."

         Payment for any Additional Securities shall be made to the Company in
Federal or other funds immediately available in New York City against delivery
of such Additional Securities for the respective accounts of the several Initial
Purchasers at 10:00 a.m., New York City time, on the date specified in the
corresponding notice described in Section 2 or at such other time on the same or
on such other date, in any event not later than January 15, 2004, as shall be
designated in writing by you.

         The Securities shall be in definitive form or global form, as specified
by you, and registered in such names and in such denominations as you shall
request in writing not later than one full business day prior to the Closing
Date or the applicable Option Closing Date, as the case may be. The Securities
shall be delivered to you on the Closing Date or an Option Closing Date, as the
case may be, for the respective accounts of the several Initial Purchasers, with
any transfer taxes payable in connection with the transfer of the Securities to
the Initial Purchasers duly paid, against payment of the Purchase Price therefor
plus accrued interest, if any, to the date of payment and delivery.

         5. Conditions to the Initial Purchasers' Obligations. The several
obligations of the Initial Purchasers to purchase and pay for the Firm
Securities on the Closing Date are subject to the following conditions:

                  (a)      Subsequent to the execution and delivery of this
         Agreement and prior to the Closing Date:

                           (i)      there shall not have occurred any
                  downgrading, nor shall any notice have been given of any
                  intended or potential downgrading or of any review for a
                  possible change that does not indicate the direction of the
                  possible change, in the rating accorded any of the Company's
                  securities by any "nationally recognized statistical rating
                  organization,"

                                       9
<PAGE>

                  as such term is defined for purposes of Rule 436(g)(2) under
                  the Securities Act; and

                           (ii)     there shall not have occurred any change, or
                  any development involving a prospective change, in the
                  condition, financial or otherwise, or in the earnings,
                  business or operations of the Company and its subsidiaries,
                  taken as a whole, from that set forth in the Preliminary
                  Memorandum provided to prospective purchasers of the
                  Securities that, in your judgment, is material and adverse and
                  that makes it, in your judgment, impracticable to market the
                  Securities on the terms and in the manner contemplated in the
                  Final Memorandum.

                  (b)      The Initial Purchasers shall have received on the
         Closing Date a certificate, dated the Closing Date and signed by an
         executive officer of the Company, to the effect set forth in Section
         5(a)(i) and to the effect that the representations and warranties of
         the Company contained in this Agreement are true and correct as of the
         Closing Date and that the Company has complied with all of the
         agreements and satisfied all of the conditions on its part to be
         performed or satisfied hereunder on or before the Closing Date. The
         officer signing and delivering such certificate may rely upon the best
         of his or her knowledge as to proceedings threatened.

                  (c)      The Initial Purchasers shall have received on the
         Closing Date the opinions of counsel for the Company, dated the Closing
         Date, to the effect set forth in Exhibit A. Such opinions shall be
         rendered to the Initial Purchasers at the request of the Company and
         shall so state therein.

                  (d)      The Initial Purchasers shall have received on the
         Closing Date an opinion of Alston & Bird LLP, counsel for the Initial
         Purchasers, dated the Closing Date, to the effect set forth in Exhibit
         B.

                  (e)      The Initial Purchasers shall have received on each of
         the date hereof and the Closing Date a letter, dated the date hereof or
         the Closing Date, as the case may be, in form and substance
         satisfactory to the Initial Purchasers, from KPMG LLP, independent
         public accountants, containing statements and information of the type
         ordinarily included in accountants' "comfort letters" to underwriters
         with respect to the financial statements and certain financial
         information contained in or incorporated by reference into each
         Memorandum; provided that the letter delivered on the Closing Date
         shall use a "cut-off date" not earlier than the date hereof.

                  (f)      The "lock-up" agreements, each substantially in the
         form of Exhibit C hereto, between you and executive officers and
         directors of the Company relating to sales and certain other
         dispositions of shares of common stock or

                                       10
<PAGE>

         certain other securities, delivered to you on or before the date
         hereof, shall be in full force and effect on the Closing Date.

         The several obligations of the Initial Purchasers to purchase
Additional Securities hereunder are subject to the delivery to you on the
applicable Option Closing Date of such documents as you may reasonably request
with respect to the good standing of the Company, the due authorization
,execution and authentication of the Additional Securities to be sold on such
Option Closing Date and other matters related to the execution and
authentication of such Additional Securities.

         6. Covenants of the Company. In further consideration of the agreements
of the Initial Purchasers contained in this Agreement, the Company covenants
with each Initial Purchaser as follows:

                  (a)      To furnish to you in New York City, without charge,
         prior to 3:00 p.m. New York City time on the business day next
         succeeding the date of this Agreement and during the period mentioned
         in Section 6(c), as many copies of the Final Memorandum, any documents
         incorporated by reference therein and any supplements and amendments
         thereto as you may reasonably request.

                  (b)      Before amending or supplementing either Memorandum,
         to furnish to you a copy of each such proposed amendment or supplement
         and not to use any such proposed amendment or supplement to which you
         reasonably object.

                  (c)      If, during such period after the date hereof and
         prior to the date on which all of the Securities shall have been sold
         by the Initial Purchasers, any event shall occur or condition exist as
         a result of which it is necessary to amend or supplement the Final
         Memorandum in order to make the statements therein, in the light of the
         circumstances when the Final Memorandum is delivered to a purchaser,
         not misleading, or if, in the opinion of counsel for the Initial
         Purchasers, it is necessary to amend or supplement the Final Memorandum
         to ensure that the Securities are exempt from the registration
         requirements of the Securities Act, forthwith to prepare and furnish,
         at its own expense, to the Initial Purchasers, either amendments or
         supplements to the Final Memorandum so that the statements in the Final
         Memorandum as so amended or supplemented will not, in the light of the
         circumstances when the Final Memorandum is delivered to a purchaser, be
         misleading or so that the Securities will be exempt from the
         registration requirements of the Securities Act.

                  (d)      To endeavor to qualify the Securities for offer and
         sale under the securities or Blue Sky laws of such jurisdictions as you
         shall reasonably request and to maintain such qualifications in effect
         for as long as may be required for distribution of the Securities by
         the Initial Purchasers.

                                       11
<PAGE>

                  (e)      To use the net proceeds received from the sale of the
         Securities in the manner specified in each Memorandum under "Use of
         Proceeds." In connection therewith, the Company shall comply with all
         U.S. laws and, specifically, shall not directly or indirectly use any
         of the net proceeds from the sale of the Securities, and shall prohibit
         any person or entity to which the Company makes such net proceeds
         available from using them, to finance the activities of any person or
         entity that is subject to sanctions under, or otherwise in a manner
         that places the Company, any affiliate thereof or any director,
         officer, employee or agent of any of the foregoing (including the
         Initial Purchasers, any affiliate thereof and each director, officer,
         employee and agent thereof) in violation of any law, regulation, order
         or license relating to any program administered by the Office of
         Foreign Assets Control ("OFAC") of the United States Department of the
         Treasury, including, without limitation, any program the regulations of
         which are codified in Chapter 5 of Subtitle B of Title 31 of the Code
         of Federal Regulations.

                  (f)      Whether or not the transactions contemplated in this
         Agreement are consummated or this Agreement is terminated, to pay or
         cause to be paid all expenses incident to the performance of its
         obligations under this Agreement, including: (i) the fees,
         disbursements and expenses of the Company's counsel and the Company's
         accountants in connection with the issuance and sale of the Securities
         and all other fees or expenses in connection with the preparation of
         each Memorandum and all amendments and supplements thereto, including
         all printing costs associated therewith, and the delivering of copies
         thereof to the Initial Purchasers, in the quantities herein above
         specified, (ii) all costs and expenses related to the transfer and
         delivery of the Securities to the Initial Purchasers, including any
         transfer or other taxes payable thereon, (iii) the cost of printing or
         producing any Blue Sky or legal investment memorandum in connection
         with the offer and sale of the Securities under state securities laws
         and all expenses in connection with the qualification of the Securities
         for offer and sale under state securities laws as provided in Section
         6(d) hereof, including filing fees and the reasonable fees and
         disbursements of counsel for the Initial Purchasers in connection with
         such qualification and in connection with the Blue Sky or legal
         investment memorandum, (iv) any fees charged by rating agencies for the
         rating of the Securities, (v) all document production charges in
         connection with the printing of this Agreement, (vi) the fees and
         expenses, if any, incurred in connection with the admission of the
         Securities for trading in PORTAL or any appropriate market system,
         (vii) the costs and charges of the Trustee and any transfer agent,
         registrar or depositary, (viii) the cost of the preparation, issuance
         and delivery of the Securities, (ix) the costs and expenses of the
         Company relating to investor presentations on any "road show"
         undertaken in connection with the marketing of the offering of the
         Securities, including, without limitation, expenses associated with the
         production of road show slides and graphics, fees and expenses of any
         consultants engaged in

                                       12
<PAGE>

         connection with the road show presentations with the prior approval of
         the Company, travel and lodging expenses of the representatives and
         officers of the Company and any such consultants, and the cost of any
         aircraft chartered in connection with the road show, and (x) all other
         costs and expenses incident to the performance of the obligations of
         the Company hereunder for which provision is not otherwise made in this
         Section. It is understood, however, that except as specifically
         provided in this Section, Section 8, and the last paragraph of Section
         10, the Initial Purchasers will pay all of their costs and expenses,
         including fees and disbursements of their counsel, transfer taxes
         payable on resale of any of the Securities by them and any advertising
         expenses connected with any offers they may make.

                  (g)      Neither the Company nor any Affiliate will sell,
         offer for sale or solicit offers to buy or otherwise negotiate in
         respect of any security (as defined in the Securities Act) which could
         be integrated with the sale of the Securities in a manner which would
         require the registration under the Securities Act of the Securities.

                  (h)      Not to solicit any offer to buy or offer or sell the
         Securities or the Underlying Securities by means of any form of general
         solicitation or general advertising (as those terms are used in
         Regulation D under the Securities Act) or in any manner involving a
         public offering within the meaning of Section 4(2) of the Securities
         Act.

                  (i)      While any of the Securities or the Underlying
         Securities remain "restricted securities" within the meaning of the
         Securities Act, to make available, upon request, to any seller of such
         Securities the information specified in Rule 144A(d)(4) under the
         Securities Act, unless the Company is then subject to Section 13 or
         15(d) of the Exchange Act.

                  (j)      If requested by you, to use its best efforts to
         permit the Securities to be designated PORTAL securities in accordance
         with the rules and regulations adopted by the National Association of
         Securities Dealers, Inc. relating to trading in the PORTAL Market.

                  (k)      During the period of two years after the Closing Date
         or any Option Closing Date, if later, the Company will not, and will
         not permit any of its affiliates (as defined in Rule 144 under the
         Securities Act) to resell any of the Securities or the Underlying
         Securities which constitute "restricted securities" under Rule 144 that
         have been reacquired by any of them.

                  (l)      Not to take any action prohibited by Regulation M
         under the Exchange Act in connection with the distribution of the
         Securities contemplated hereby.

                                       13
<PAGE>

         7. Offering of Securities; Restrictions on Transfer. Each Initial
Purchaser, severally and not jointly, represents and warrants that such Initial
Purchaser is a qualified institutional buyer as defined in Rule 144A under the
Securities Act (a "QIB") and an "accredited investor" within the meaning of Rule
501(a) of the Securities Act. Each Initial Purchaser, severally and not jointly,
agrees with the Company that (a) it will solicit offers for, offer and sell the
Securities only to persons inside the United States, (b) it will not solicit
offers for, or offer or sell, such Securities by any form of general
solicitation or general advertising (as those terms are used in Regulation D
under the Securities Act) or in any manner involving a public offering within
the meaning of Section 4(2) of the Securities Act and (c) it will solicit offers
for such Securities only from, and will offer such Securities only to, persons
that it reasonably believes to be, QIBs that, prior to their purchase of the
Securities, deliver to such Initial Purchaser a letter containing the
representations and agreements confirming their status as QIBs and other
relevant matters.

         8. Indemnity and Contribution. (a) The Company agrees to indemnify and
hold harmless each Initial Purchaser, each person, if any, who controls any
Initial Purchaser within the meaning of either Section 15 of the Securities Act
or Section 20 of the Exchange Act, and each affiliate of any Initial Purchaser
within the meaning of Rule 405 under the Securities Act from and against any and
all losses, claims, damages and liabilities (including, without limitation, any
legal or other expenses reasonably incurred in connection with defending or
investigating any such action or claim) caused by any untrue statement or
alleged untrue statement of a material fact contained in either Memorandum (as
amended or supplemented if the Company shall have furnished any amendments or
supplements thereto), or caused by any omission or alleged omission to state
therein a material fact necessary to make the statements therein in the light of
the circumstances under which they were made not misleading, except insofar as
such losses, claims, damages or liabilities are caused by any such untrue
statement or omission or alleged untrue statement or omission based upon
information relating to any Initial Purchaser furnished to the Company in
writing by such Initial Purchaser through you expressly for use therein;
provided, however, that the foregoing indemnity agreement with respect to any
preliminary offering memorandum shall not inure to the benefit of any Initial
Purchaser from whom the person asserting any such losses, claims, damages or
liabilities purchased Securities, or any person controlling such Initial
Purchaser, if a copy of the Final Memorandum (as then amended or supplemented if
the Company shall have furnished any amendments or supplements thereto) was not
sent or given by or on behalf of such Initial Purchaser to such person, if
required by law so to have been delivered, at or prior to the written
confirmation of the sale of the Securities to such person, and if the Final
Memorandum (as so amended or supplemented) would have cured the defect giving
rise to such losses, claims, damages or liabilities, unless such failure is the
result of noncompliance by the Company with Section 6(a) hereof.

                                       14
<PAGE>

         (b)      Each Initial Purchaser agrees, severally and not jointly, to
indemnify and hold harmless the Company, its directors, its officers and each
person, if any, who controls the Company within the meaning of either Section 15
of the Securities Act or Section 20 of the Exchange Act to the same extent as
the foregoing indemnity from the Company to such Initial Purchaser, but only
with reference to information relating to such Initial Purchaser furnished to
the Company in writing by such Initial Purchaser expressly for use in either
Memorandum or any amendments or supplements thereto.

         (c)      In case any proceeding (including any governmental
investigation) shall be instituted involving any person in respect of which
indemnity may be sought pursuant to Section 8(a) or 8(b), such person (the
"INDEMNIFIED PARTY") shall promptly notify the person against whom such
indemnity may be sought (the "INDEMNIFYING PARTY") in writing and the
indemnifying party, upon request of the indemnified party, shall retain counsel
reasonably satisfactory to the indemnified party to represent the indemnified
party and any others the indemnifying party may designate in such proceeding and
shall pay the fees and disbursements of such counsel related to such proceeding.
In any such proceeding, any indemnified party shall have the right to retain its
own counsel, but the fees and expenses of such counsel shall be at the expense
of such indemnified party unless (i) the indemnifying party and the indemnified
party shall have mutually agreed to the retention of such counsel or (ii) the
named parties to any such proceeding (including any impleaded parties) include
both the indemnifying party and the indemnified party and representation of both
parties by the same counsel would be inappropriate due to actual or potential
differing interests between them. It is understood that the indemnifying party
shall not, in respect of the legal expenses of any indemnified party in
connection with any proceeding or related proceedings in the same jurisdiction,
be liable for the fees and expenses of more than one separate firm (in addition
to any local counsel) for all such indemnified parties and that all such fees
and expenses shall be reimbursed as they are incurred. Such firm shall be
designated in writing by Morgan Stanley & Co. Incorporated, in the case of
parties indemnified pursuant to Section 8(a), and by the Company, in the case of
parties indemnified pursuant to Section 8(b). The indemnifying party shall not
be liable for any settlement of any proceeding effected without its written
consent, but if settled with such consent or if there be a final judgment for
the plaintiff, the indemnifying party agrees to indemnify the indemnified party
from and against any loss or liability by reason of such settlement or judgment.
Notwithstanding the foregoing sentence, if at any time an indemnified party
shall have requested an indemnifying party to reimburse the indemnified party
for fees and expenses of counsel as contemplated by the second and third
sentences of this paragraph, the indemnifying party agrees that it shall be
liable for any settlement of any proceeding effected without its written consent
if (i) such settlement is entered into more than 30 days after receipt by such
indemnifying party of the aforesaid request and (ii) such indemnifying party
shall not have reimbursed the indemnified party in accordance with such request
prior to the date of such settlement. No indemnifying party shall, without the
prior written consent of the indemnified party, effect any settlement of any
pending or threatened proceeding in respect of which any indemnified

                                       15
<PAGE>

party is or could have been a party and indemnity could have been sought
hereunder by such indemnified party, unless such settlement includes an
unconditional release of such indemnified party from all liability on claims
that are the subject matter of such proceeding.

         (d)      To the extent the indemnification provided for in Section 8(a)
or 8(b) is unavailable to an indemnified party or insufficient in respect of any
losses, claims, damages or liabilities referred to therein, then each
indemnifying party under such paragraph, in lieu of indemnifying such
indemnified party thereunder, shall contribute to the amount paid or payable by
such indemnified party as a result of such losses, claims, damages or
liabilities (i) in such proportion as is appropriate to reflect the relative
benefits received by the Company on the one hand and the Initial Purchasers on
the other hand from the offering of the Securities or (ii) if the allocation
provided by clause 8(d)(i) above is not permitted by applicable law, in such
proportion as is appropriate to reflect not only the relative benefits referred
to in clause 8(d)(i) above but also the relative fault of the Company on the one
hand and of the Initial Purchasers on the other hand in connection with the
statements or omissions that resulted in such losses, claims, damages or
liabilities, as well as any other relevant equitable considerations. The
relative benefits received by the Company on the one hand and the Initial
Purchasers on the other hand in connection with the offering of the Securities
shall be deemed to be in the same respective proportions as the net proceeds
from the offering of the Securities (before deducting expenses) received by the
Company and the total discounts and commissions received by the Initial
Purchasers, as set forth in the Final Memorandum, bear to the aggregate offering
price of the Securities. The relative fault of the Company on the one hand and
of the Initial Purchasers on the other hand shall be determined by reference to,
among other things, whether the untrue or alleged untrue statement of a material
fact or the omission or alleged omission to state a material fact relates to
information supplied by the Company or by the Initial Purchasers and the
parties' relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission. The Initial Purchasers'
respective obligations to contribute pursuant to this Section 8 are several in
proportion to the respective principal amount of Securities they have purchased
hereunder, and not joint.

         (e)      The Company and the Initial Purchasers agree that it would not
be just or equitable if contribution pursuant to this Section 8 were determined
by pro rata allocation (even if the Initial Purchasers were treated as one
entity for such purpose) or by any other method of allocation that does not take
account of the equitable considerations referred to in Section 8(d). The amount
paid or payable by an indemnified party as a result of the losses, claims,
damages and liabilities referred to in Section 8(d) shall be deemed to include,
subject to the limitations set forth above, any legal or other expenses
reasonably incurred by such indemnified party in connection with investigating
or defending any such action or claim. Notwithstanding the provisions of this
Section 8, no Initial Purchaser shall be required to contribute any amount in
excess of the amount by which the total price at which the Securities resold

                                       16
<PAGE>

by it in the initial placement of such Securities were offered to investors
exceeds the amount of any damages that such Initial Purchaser has otherwise been
required to pay by reason of such untrue or alleged untrue statement or omission
or alleged omission. No person guilty of fraudulent misrepresentation (within
the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent
misrepresentation. The remedies provided for in this Section 8 are not exclusive
and shall not limit any rights or remedies which may otherwise be available to
any indemnified party at law or in equity.

         (f)      The indemnity and contribution provisions contained in this
Section 8 and the representations, warranties and other statements of the
Company contained in this Agreement shall remain operative and in full force and
effect regardless of (i) any termination of this Agreement, (ii) any
investigation made by or on behalf of any Initial Purchaser, any person
controlling any Initial Purchaser or any affiliate of any Initial Purchaser or
by or on behalf of the Company, its officers or directors or any person
controlling the Company and (iii) acceptance of and payment for any of the
Securities.

         9. Termination. The Initial Purchasers may terminate this Agreement by
notice given by you to the Company, if after the execution and delivery of this
Agreement and prior to the Closing Date (i) trading generally shall have been
suspended or materially limited on, or by, as the case may be, any of the New
York Stock Exchange, the American Stock Exchange, the Nasdaq National Market,
the Chicago Board of Options Exchange, the Chicago Mercantile Exchange or the
Chicago Board of Trade, (ii) trading of any securities of the Company shall have
been suspended on any exchange or in any over-the-counter market, (iii) a
material disruption in securities settlement, payment or clearance services in
the United States shall have occurred, (iv) any moratorium on commercial banking
activities shall have been declared by Federal or New York State authorities or
(v) there shall have occurred any outbreak or escalation of hostilities, or any
change in financial markets or any calamity or crisis that, in your judgment, is
material and adverse and which, singly or together with any other event
specified in this clause (v), makes it, in your judgment, impracticable or
inadvisable to proceed with the offer, sale or delivery of the Securities on the
terms and in the manner contemplated in the Final Memorandum.

         10. Effectiveness; Defaulting Initial Purchasers. This Agreement shall
become effective upon the execution and delivery hereof by the parties hereto.

         If on the Closing Date, or an Option Closing Date, as the case may be,
any one or more of the Initial Purchasers shall fail or refuse to purchase
Securities that it or they have agreed to purchase hereunder on such date, and
the aggregate principal amount of Securities which such defaulting Initial
Purchaser or Initial Purchasers agreed but failed or refused to purchase is not
more than one-tenth of the aggregate principal amount of Securities to be
purchased on such date, the other Initial Purchasers shall be obligated
severally in the proportions that the principal amount of Firm Securities set
forth

                                       17
<PAGE>

opposite their respective names in Schedule I bears to the aggregate principal
amount of Firm Securities set forth opposite the names of all such
non-defaulting Initial Purchasers, or in such other proportions as you may
specify, to purchase the Securities which such defaulting Initial Purchaser or
Initial Purchasers agreed but failed or refused to purchase on such date;
provided that in no event shall the principal amount of Securities that any
Initial Purchaser has agreed to purchase pursuant to this Agreement be increased
pursuant to this Section 10 by an amount in excess of one-ninth of such
principal amount of Securities without the written consent of such Initial
Purchaser. If, on the Closing Date any Initial Purchaser or Initial Purchasers
shall fail or refuse to purchase Firm Securities which it or they have agreed to
purchase hereunder on such date and the aggregate principal amount of Securities
with respect to which such default occurs is more than one-tenth of the
aggregate principal amount of Firm Securities to be purchased on such date, and
arrangements satisfactory to you and the Company for the purchase of such Firm
Securities are not made within 36 hours after such default, this Agreement shall
terminate without liability on the part of any non-defaulting Initial Purchaser
or of the Company. In any such case either you or the Company shall have the
right to postpone the Closing Date, but in no event for longer than seven days,
in order that the required changes, if any, in the Final Memorandum or in any
other documents or arrangements may be effected. If, on an Option Closing Date,
any Initial Purchaser or Initial Purchasers shall fail or refuse to purchase
Additional Securities and the aggregate principal amount of Additional
Securities with respect to which such default occurs is more than one-tenth of
the aggregate principal amount of Additional Securities to be purchased on such
Option Closing Date, the non-defaulting Initial Purchasers shall have the option
to (a) terminate their obligation hereunder to purchase the Additional
Securities to be sold on such Option Closing Date or (b) purchase not less than
the principal amount of Additional Securities that such non-defaulting Initial
Purchasers would have been obligated to purchase in the absence of such default.
Any action taken under this paragraph shall not relieve any defaulting Initial
Purchaser from liability in respect of any default of such Initial Purchaser
under this Agreement.

         If this Agreement shall be terminated by the Initial Purchasers, or any
of them, because of any failure or refusal on the part of the Company to comply
with the terms or to fulfill any of the conditions of this Agreement, or if for
any reason the Company shall be unable to perform its obligations under this
Agreement, the Company will reimburse the Initial Purchasers, or such Initial
Purchasers as have so terminated this Agreement with respect to themselves,
severally, for all out-of-pocket expenses (including the fees and disbursements
of their counsel) reasonably incurred by such Initial Purchasers in connection
with this Agreement or the offering contemplated hereunder.

         11. Counterparts. This Agreement may be signed in any number of
counterparts, each of which shall be an original, with the same effect as if the
signatures thereto and hereto were upon the same instrument.

         12. Applicable Law. This Agreement shall be governed by and construed
in accordance with the internal laws of the State of New York.

                                       18
<PAGE>

         13. Headings. The headings of the sections of this Agreement have been
inserted for convenience of reference only and shall not be deemed a part of
this Agreement.

                                       Very truly yours,

                                       AGCO Corporation

                                       By: /s/ Andrew Beck
                                           ------------------------------------
                                           Name:  Andrew Beck
                                           Title: Chief Financial Officer

Accepted as of the date hereof

Morgan Stanley & Co. Incorporated
Rabo Securities USA, Inc.
Acting severally on behalf of themselves
     and the several Initial Purchasers named
     in Schedule I hereto.

By: Morgan Stanley & Co. Incorporated

By: /s/ Trevor R. Burgess
    -----------------------------------------
    Name:  Trevor R. Burgess
    Title: Executive Director

                                       19
<PAGE>

                                                                      SCHEDULE I

<TABLE>
<CAPTION>
                                                                   PRINCIPAL AMOUNT OF FIRM
                   INITIAL PURCHASER                              SECURITIES TO BE PURCHASED
<S>                                                               <C>
Morgan Stanley & Co. Incorporated.........................               $ 132,475,000
Rabo Securities USA, Inc..................................                  42,525,000

           Total..........................................               $ 175,000,000
                                                                         =============
</TABLE>

                                       B-1<PAGE>

                                                                    EXHIBIT 10.6

                            INDEMNIFICATION AGREEMENT

         THIS INDEMNIFICATION AGREEMENT, dated as of the ____ day of ________,
200_, between PEDIATRIX MEDICAL GROUP, INC., a Florida corporation (the
"Company"), and __________________, (the "Indemnitee").

                                    RECITALS

         A.       The Indemnitee is currently serving as a director and/or
executive officer of the Company and the Company desires to continue to retain
the services of the Indemnitee as a director and/or executive officer of the
Company.

         B.       The Company and the Indemnitee recognize the increased risk of
litigation and other claims being asserted against directors and officers of
public companies and the subsidiaries of such companies.

         C.       The Amended and Restated Articles of Incorporation (the
"Articles of Incorporation") of the Company provide for indemnification to its
directors and officers and eliminates or limits the liability of a director or
officer to the fullest extent permitted by the Florida Business Corporation Act
(the "Florida Act"), and the Indemnitee has been serving and continues to serve
as a director and/or officer of the Company, in part, in reliance on such
provisions of the Articles of Incorporation.

         D.       The Indemnitee has indicated that the Indemnitee does not
regard the indemnities available under the Company's Articles of Incorporation
and bylaws and available insurance, if any, as adequate to protect the
Indemnitee against the risks associated with services by the Indemnitee to the
Company. As a condition to the Indemnitee's agreement to continue to serve as
such, the Indemnitee requires that the Indemnitee be indemnified from liability
in accordance with the provisions of this Agreement to the fullest extent
permitted by law.

         E.       The Company recognizes that the Indemnitee needs substantial
protection against personal liability in order to maintain the Indemnitee's
continued service to the Company in an effective manner and is willing to
indemnify the Indemnitee in accordance with the provisions of this Agreement to
the fullest extent permitted by law in order to continue to retain the services
of the Indemnitee.

         F.       The Company desires to provide in this Agreement for
indemnification of, and the advance of expenses to, Indemnitee to the fullest
extent (whether partial or complete) permitted by law, as set forth in this
Agreement and, to the extent officers' and directors' liability insurance is
maintained by the Company, to provide for the continued coverage of the
Indemnitee under the Company's officers' and directors' liability insurance
policies, in part to provide the Indemnitee with specific contractual assurance
that the protection promised by the indemnification provisions of the Articles
of Incorporation will be available to the Indemnitee

<PAGE>

(regardless of, among other things, any amendment to or revocation of such
provisions of the Articles of Incorporation or any change in the composition of
the Company's Board of Directors or any acquisition transaction relating to the
Company).

         NOW, THEREFORE, for and in consideration of the premises and the mutual
covenants contained herein and the Indemnitee's past and continued service to
the Company, the Company and the Indemnitee agree as follows:

         SECTION 1. INDEMNIFICATION IN PROCEEDINGS OTHER THAN THOSE BY OR IN THE
RIGHT OF THE COMPANY. Subject to Sections 4 and 13 hereof, the Company shall
indemnify and hold harmless the Indemnitee from and against any and all claims,
damages, expenses, costs (including attorneys' fees and costs of other
professionals), judgments, penalties, fines (including excise taxes assessed
with respect to an employee benefit plan), settlements, and all other
liabilities incurred or paid by the Indemnitee in connection with the
investigation, defense, prosecution, settlement or appeal of, or being or
preparing to be a witness in, or participating in, any threatened, pending or
completed action, suit, investigation that the Indemnitee in good faith believes
might lead to the institution of such action, or proceeding, whether civil,
criminal, administrative or investigative (other than an action by or in the
right of the Company) and to which the Indemnitee was or is a party or is
threatened to be made a party or was or is a witness or participates or may
participate in by reason of the fact that the Indemnitee is or was an officer,
director, manager, consultant, stockholder, employee or agent of the Company or
any of its subsidiaries, or is or was serving at the request of the Company or
any of its subsidiaries as an officer, director, consultant, partner, trustee,
employee or agent of another corporation, partnership, joint venture, trust,
employee benefit plan or other enterprise, or by reason of anything done or not
done by the Indemnitee in any such capacity or capacities, provided that the
Indemnitee acted in good faith and in a manner the Indemnitee reasonably
believed to be in or not opposed to the best interests of the Company and, with
respect to any criminal action or proceeding, had no reasonable cause to believe
that the Indemnitee's conduct was unlawful.

         SECTION 2. INDEMNIFICATION IN PROCEEDINGS BY OR IN THE RIGHT OF THE
COMPANY. Subject to Sections 4 and 13 hereof, the Company shall indemnify and
hold harmless the Indemnitee from and against any and all expenses (including
attorneys' fees) and amounts paid in settlement actually and reasonably incurred
by the Indemnitee in connection with the investigation, defense, prosecution,
settlement or appeal of, or being or preparing to be a witness in, or
participating in, any threatened, pending or completed action, suit,
investigation that the Indemnitee in good faith believes might lead to the
institution of such action, or proceeding by or in the right of the Company to
procure a judgment in its favor, whether civil, criminal, administrative or
investigative, and to which the Indemnitee was or is a party or is threatened to
be made a party or was or is a witness or participate or may participate in by
reason of the fact that the Indemnitee is or was an officer, director, manager,
consultant, stockholder, employee or agent of the Company or any of its
subsidiaries, or is or was serving at the request of the Company or any of its
subsidiaries as an officer, director, consultant, partner, trustee, employee or
agent of another corporation, partnership, joint venture, trust, employee
benefit plan or other enterprise, or by reason of anything done or not done by
the Indemnitee in any such capacity or capacities, provided that (i) the
Indemnitee acted in good faith and in a manner the Indemnitee reasonably
believed to be in or not opposed to the best interests of the Company, (ii)

                                       2

<PAGE>

indemnification for amounts paid in settlement shall not exceed the estimated
expense of litigating the proceeding to conclusion and (iii) no indemnification
shall be made under this Section 2 in respect of any claim, issue or matter as
to which the Indemnitee shall have been adjudged to be liable unless, and only
to the extent that, the court in which such proceeding was brought (or any other
court of competent jurisdiction) shall determine upon application that, despite
the adjudication of such liability but in view of all the circumstances of the
case, the Indemnitee is fairly and reasonably entitled to indemnity for such
expenses which such court shall deem proper.

         SECTION 3. REIMBURSEMENT OF EXPENSES FOLLOWING ADJUDICATION OF
NEGLIGENCE. Subject to Sections 4 and 13 hereof, the Company shall reimburse the
Indemnitee for any expenses (including attorney's fees) and amounts paid in
settlement actually and reasonably incurred by the Indemnitee in connection with
the investigation, defense, settlement or appeal of any action, suit or
proceeding described in Section 2 hereof that results in an adjudication that
the Indemnitee was liable, other than for willful misconduct in the performance
of his duty to the Company; provided, however, that the Indemnitee acted in good
faith and in a manner the Indemnitee believed to be in the best interests of the
Company.

         SECTION 4. AUTHORIZATION OF INDEMNIFICATION OR REIMBURSEMENT. Any
indemnification under Sections 1 and 2 hereof (unless ordered by a court) and
any reimbursement made under Section 3 hereof shall be made by the Company only
as authorized in the specific case upon a determination (the "Determination")
that indemnification or reimbursement of the Indemnitee is proper in the
circumstances because the Indemnitee has met the applicable standard of conduct
set forth in Section 1, 2 or 3 hereof, as the case may be. Subject to Sections
5.5, 5.6 and 8 of this Agreement, the Determination shall be made in the
following order of preference:

                           (1) first, by the Company's Board of Directors (the
"Board") by majority vote or consent of a quorum consisting of directors
("Disinterested Directors") who are not, at the time of the Determination, named
parties to such action, suit or proceeding; or

                           (2) next, if such a quorum of Disinterested Directors
cannot be obtained, by majority vote or consent of a committee duly designated
by the Board (in which designation all directors, whether or not Disinterested
Directors, may participate) consisting solely of two or more Disinterested
Directors; or

                           (3) next, if such a committee cannot be designated,
by any independent legal counsel selected in accordance with Section 5.5.

         4.1.     No Presumptions. The termination of any action, suit or
proceeding by judgment, order, settlement, conviction, or upon a plea of nolo
contendere or its equivalent, shall not, of itself, create a presumption that
the Indemnitee did not act in good faith and in a manner that the Indemnitee
reasonably believed to be in or not opposed to the best interests of the
Company, and with respect to any criminal action or proceeding, knew that the
Indemnitee's conduct was unlawful.

                                       3
<PAGE>

         4.2.     Benefit Plan Conduct. The Indemnitee's conduct with respect to
an employee benefit plan for a purpose the Indemnitee reasonably believed to be
in the interests of the participants in and beneficiaries of the plan shall be
deemed to be conduct that the Indemnitee reasonably believed to be not opposed
to the best interests of the Company.

         4.3.     Reliance as Safe Harbor. For purposes of any Determination
hereunder, the Indemnitee shall be deemed to have acted in good faith and in a
manner the Indemnitee reasonably believed to be in or not opposed to the best
interests of the Company or, with respect to any criminal action or proceeding,
to have had no reasonable cause to believe or did not know the Indemnitee's
conduct was unlawful, if the Indemnitee's action is based on (i) the records or
books of account of the Company or another enterprise, including financial
statements, (ii) information supplied to the Indemnitee by the officers of the
Company or another enterprise in the course of their duties, (iii) the advice of
legal counsel for the Company or another enterprise, or (iv) information or
records given or reports made to the Company or another enterprise by an
independent certified public accountant or by an appraiser or other expert
selected with reasonable care by the Company or another enterprise. The term
"another enterprise" as used in this Section 4.3 shall mean any other
corporation or any partnership, joint venture, trust, employee benefit plan or
other enterprise of which the Indemnitee is or was serving at the request of the
Company or any of its subsidiaries as an officer, director, consultant, partner,
trustee, employee or agent. The provisions of this Section 4.3 shall not be
deemed to be exclusive or to limit in any way the other circumstances in which
the Indemnitee may be deemed to have met the applicable standard of conduct set
forth in Sections 1, 2 or 3 hereof, as the case may be.

         4.4.     Success on Merits or Otherwise. To the extent that the
Indemnitee has been successful on the merits or otherwise in defense of any
action, suit or proceeding described in Section 1 or 2 hereof, or in defense of
any claim, issue or matter therein, the Indemnitee shall be indemnified against
expenses (including attorneys' fees) actually and reasonably incurred by the
Indemnitee in connection with the investigation, defense, settlement or appeal
thereof. For purposes of this Section 4.4, the term "successful on the merits or
otherwise" shall include, but not be limited to, (i) any termination,
withdrawal, or dismissal (with or without prejudice) of any claim, action, suit
or proceeding against the Indemnitee without any express finding of liability or
guilt against the Indemnitee, (ii) the expiration of 120 days after the making
of any claim or threat of an action, suit or proceeding without the institution
of the same and without any promise or payment made to induce a settlement, or
(iii) the settlement of any action, suit or proceeding under Section 1, 2 or 3
hereof pursuant to which the Indemnitee pays less than $25,000.

         4.5.     Partial Indemnification or Reimbursement. If the Indemnitee is
entitled under any provision of this Agreement to indemnification and/or
reimbursement by the Company for some or a portion of the claims, damages,
expenses (including attorneys' fees and costs of other professionals),
judgments, fines or amounts paid in settlement by the Indemnitee in connection
with the investigation, defense, settlement or appeal of any action specified in
Section 1, 2 or 3 hereof, but not, however, for the total amount thereof, the
Company shall nevertheless indemnify and/or reimburse the Indemnitee for the
portion thereof to which the Indemnitee is entitled. The party or parties making
the Determination shall determine the portion (if less than all) of such claims,
damages, expenses (including attorneys' fees), judgments, fines or amounts paid
in

                                       4
<PAGE>

settlement for which the Indemnitee is entitled to indemnification and/or
reimbursement under this Agreement.

         SECTION 5. PROCEDURES FOR DETERMINATION OF WHETHER STANDARDS HAVE BEEN
SATISFIED.

         5.1.     Costs. All costs of making any Determination required by
Section 4 or 5 hereof shall be borne solely by the Company, including, but not
limited to, the costs of legal counsel and judicial determinations. The Company
shall also be solely responsible for paying (i) all reasonable expenses incurred
by the Indemnitee to enforce this Agreement, including, but not limited to, the
costs incurred by the Indemnitee to obtain court-ordered indemnification
pursuant to Section 8 hereof, regardless of the outcome of any such application
or proceeding, and (ii) all costs of defending any suits or proceedings
challenging payments to the Indemnitee under this Agreement.

         5.2.     Timing of the Determination. The Company shall use its best
efforts to make the Determination contemplated by Section 4 or 5 hereof
promptly. In addition, the Company agrees:

                  (a) if the Determination is to be made by the Board or a
committee thereof, such Determination shall be made not later than 15 days after
a written request for a Determination (a "Request") is delivered to the Company
by the Indemnitee; and

                  (b) if the Determination is to be made by independent legal
counsel, such Determination shall be made not later than 30 days after a Request
is delivered to the Company by the Indemnitee.

The failure to make a Determination within the above-specified time period shall
constitute a Determination approving full indemnification or reimbursement of
the Indemnitee. Notwithstanding anything herein to the contrary, the
Determination may be made in advance of (i) the Indemnitee's payment (or
incurring) of expenses with respect to which indemnification or reimbursement is
sought, and/or (ii) final disposition of the action, suit or proceeding with
respect to which indemnification or reimbursement is sought.

         5.3.     Reasonableness of Expenses. The evaluation and finding as to
the reasonableness of expenses incurred by the Indemnitee for purposes of this
Agreement shall be made (in the following order of preference) within 15 days of
the Indemnitee's delivery to the Company of a Request that includes a reasonable
accounting of expenses incurred:

                  (a)      first, by the Board by a majority vote of a quorum
consisting of Disinterested Directors; or

                  (b)      next, if a quorum of Disinterested Directors cannot
be obtained by majority vote or consent of a committee duly designated by the
Board (in which designation all directors, whether or not Disinterested
Directors, may participate), consisting solely of two or more Disinterested
Directors; or

                                       5
<PAGE>

                  (c)      next, if such a committee cannot be designated, by
any independent legal counsel selected in accordance with Section 5.5; provided,
that, if the determination for authorization of Indemnification was made by
independent counsel pursuant to Section 4(3) hereof, then the evaluation and
finding of reasonableness shall in all events be made by independent legal
counsel.

All expenses shall be considered reasonable for purposes of this Agreement if
the finding contemplated by this Section 5.3 is not made within the prescribed
time. The finding required by this Section 5.3 may be made in advance of the
payment (or incurring) of the expenses for which indemnification or
reimbursement is sought.

         5.4.     Payment of Indemnified Amount. Immediately following a
Determination that the Indemnitee has met the applicable standard of conduct set
forth in Section 1, 2 or 3 hereof, as the case may be, and the finding of
reasonableness of expenses contemplated by Section 5.3 hereof, or the passage of
time prescribed for making such determination(s), the Company shall pay to the
Indemnitee in cash the amount to which the Indemnitee is entitled to be
indemnified and/or reimbursed, as the case may be, without further authorization
or action by the Board; provided, however, that the expenses for which
indemnification or reimbursement is sought have actually been incurred by the
Indemnitee.

         5.5.     Selection of Independent Legal Counsel. If the Determination
required under Section 4 or 5 is to be made by independent legal counsel, such
counsel shall be selected by the Board described in Section 4(1) hereof or the
committee of the Board described in Section 4(2) hereof. The fees and expenses
incurred by counsel in making any Determination (including Determinations
pursuant to Section 5.7 hereof) shall be borne solely by the Company regardless
of the results of any Determination and, if requested by counsel, the Company
shall give such counsel an appropriate written agreement with respect to the
payment of their fees and expenses and such other matters as may be reasonably
requested by counsel.

         5.6.     Right of Indemnitee to Appeal an Adverse Determination by
Board. If a Determination is made by the Board or a committee thereof that the
Indemnitee did not meet the applicable standard of conduct set forth in Section
1, 2 or 3 hereof or that the Indemnitee's expenses are not reasonable as set
forth in Section 5.3 hereof, upon the written request of the Indemnitee and the
Indemnitee's delivery of $5,000 to the Company, the Company shall cause a new
Determination to be made by independent legal counsel, which independent legal
counsel shall be selected in accordance with Section 5.5. Subject to Section 8
hereof, such Determination by such independent legal counsel shall be binding
and conclusive for all purposes of this Agreement.

         5.7.     Right of Indemnitee To Select Forum For Determination. If, at
any time subsequent to the date of this Agreement, "Continuing Directors" do not
constitute a majority of the members of the Board, or there is otherwise a
change in control of the Company (as contemplated by Item 403(c) of Regulation
S-K), then the Determination required by Section 4 or 5 hereof shall be made by
independent legal counsel selected by the Indemnitee and approved by the Board
(which approval shall not be unreasonably withheld), which counsel shall be
deemed to satisfy the requirements of clause (3) of Section 4 and clause (c) of
Section 5.3 hereof. If none of the legal counsel selected by the Indemnitee are
willing and/or able to make the

                                       6
<PAGE>

Determination, then the Company shall cause the Determination to be made by a
majority vote or consent of a Board committee consisting solely of Continuing
Directors. For purposes of this Agreement, a "Continuing Director" means either
a member of the Board at the date of this Agreement or a person nominated to
serve as a member of the Board by a majority of the then Continuing Directors.

         5.8.     Access by Indemnitee to Determination. The Company shall
afford to the Indemnitee and the Indemnitee's representatives ample opportunity
to present evidence of the facts upon which the Indemnitee relies for
indemnification or reimbursement, together with other information relating to
any requested Determination.

         5.9.     Judicial Determinations in Derivative Suits. In each action or
suit described in Section 2 hereof, the Company shall cause its counsel to use
its best efforts to obtain from the Court in which such action or suit was
brought (i) an express adjudication whether the Indemnitee is liable for
negligence or misconduct in the performance of his duty to the Company, and, if
the Indemnitee is so liable, (ii) a determination whether and to what extent,
despite the adjudication of liability but in view of all the circumstances of
the case (including this Agreement), the Indemnitee is fairly and reasonably
entitled to indemnification.

         5.10.    Burden of Proof. In the event of any claim by the Indemnitee
for indemnification hereunder, there shall be a presumption that the Indemnitee
is entitled to indemnification hereunder and the Company shall have the burden
of proving that the Indemnitee is not entitled to such indemnification.

         SECTION 6. SCOPE OF INDEMNITY. The actions, suits and proceedings
described in Sections 1 and 2 hereof shall include, for purposes of this
Agreement, any actions that involve, directly or indirectly, activities of the
Indemnitee both in his official capacities as a Company director or officer and
actions taken in another capacity while serving as director or officer,
including, but not limited to, actions or proceedings involving (i) compensation
paid to the Indemnitee by the Company, (ii) activities by the Indemnitee on
behalf of the Company, including actions in which the Indemnitee is plaintiff,
(iii) actions alleging a misappropriation of a "corporate opportunity," (iv)
responses to a takeover attempt or threatened takeover attempt of the Company,
(v) transactions by the Indemnitee in Company securities, and (vi) the
Indemnitee's preparation for and appearance (or potential appearance) as a
witness in any proceeding relating, directly or indirectly, to the Company. In
addition, the Company agrees that, for purposes of this Agreement, all services
performed by the Indemnitee on behalf of, in connection with or related to any
subsidiary of the Company, any employee benefit plan established for the benefit
of employees of the Company or any subsidiary, any corporation or partnership or
other entity in which the Company or any subsidiary has a 5% ownership interest,
or any other affiliate shall be deemed to be at the request of the Company.

         SECTION 7. ADVANCE FOR EXPENSES.

         7.1.     Mandatory Advance. Expenses (including attorneys' fees)
incurred by the Indemnitee in investigating, defending, settling or appealing,
or being or preparing to be a witness in, any action, suit or proceeding
described in Section 1 or 2 hereof shall, subject to Section 13 hereof, be paid
by the Company in advance of the final disposition of such action, suit

                                       7
<PAGE>

or proceeding. The Company shall promptly pay the amount of such expenses to the
Indemnitee, but in no event later than 5 days following the Indemnitee's
delivery to the Company of a written request for an advance pursuant to this
Section 7, together with a reasonable accounting of such expenses.

         7.2.     Undertaking to Repay. The Indemnitee hereby undertakes and
agrees to repay to the Company any advances made pursuant to this Section 7 if
and to the extent that a court of competent jurisdiction shall make a final
judgment (as to which all rights of appeal therefrom have been exhausted or
lapsed) that the Indemnitee is not entitled to be indemnified by the Company for
such amounts or such advances were in violation of Section 13 hereof.

         7.3.     Miscellaneous. The Company shall make the advances
contemplated by this Section 7 regardless of the Indemnitee's financial ability
to make repayment, and regardless whether indemnification of the Indemnitee by
the Company will ultimately be required. Any advances and undertakings to repay
pursuant to this Section 7 shall be unsecured and interest-free.

         SECTION 8. COURT-ORDERED INDEMNIFICATION. Regardless of whether the
Indemnitee has met the standard of conduct set forth in Sections 1, 2 or 3
hereof, as the case may be, and notwithstanding the presence or absence of any
Determination whether such standards have been satisfied and notwithstanding any
other provision hereof, the Indemnitee may apply for indemnification (and/or
reimbursement pursuant to Section 3 or 12 hereof) to the court conducting any
proceeding to which the Indemnitee is a party or a witness or to any other court
of competent jurisdiction. On receipt of an application, the court, after giving
any notice the court considers necessary, may order indemnification (and/or
reimbursement) if it determines the Indemnitee is fairly and reasonably entitled
to indemnification (and/or reimbursement) in view of all the relevant
circumstances (including this Agreement).

         SECTION 9. CONTRIBUTION. If and to the extent that a final adjudication
shall specify that the Company is not obligated to indemnify Indemnitee under
this Agreement for any reason (by reason of public policy, as a matter of law or
otherwise), then in respect of any threatened, pending or completed action, suit
or proceeding in which the Company is jointly liable with Indemnitee (or would
be so liable if joined in such action, suit or proceeding), the Company shall
contribute to the amount of expenses (including attorneys' fees and costs of
other professionals), judgments, penalties, fines (including excise taxes
assessed), settlements and all other liabilities incurred and paid or payable by
Indemnitee in connection with such action, suit or proceeding in such proportion
as is appropriate to reflect (i) the relative benefits received by the Company
on the one hand and Indemnitee on the other hand from the transaction with
respect to which such action, suit or proceeding arose, and (ii) the relative
fault of the Company on the one hand and of Indemnitee on the other hand in
connection with the circumstances which resulted in such expenses, judgments,
fines or settlement amounts, as well as any other relevant equitable
considerations. The relative fault of the Company on the one hand and of
Indemnitee on the other hand shall be determined by reference to among other
things, the parties' relative intent, knowledge, access to information and
opportunity to correct or prevent the circumstances resulting in such expense,
judgments, fines or settlement amounts. The Company agrees that it would not be
just and equitable if contribution pursuant to this Section 9 were determined by
pro

                                       8
<PAGE>

rata allocation or any other method of allocation which does not take account of
the foregoing equitable considerations.

         SECTION 10. NONDISCLOSURE OF PAYMENTS. Except as required by law,
neither party shall disclose any payments under this Agreement unless prior
approval of the other party is obtained. Any payments to the Indemnitee that
must be disclosed shall, unless otherwise required by law, be described only in
Company proxy or information statements relating to special and/or annual
meetings of the Company's shareholders, and the Company shall afford the
Indemnitee the reasonable opportunity to review all such disclosures and, if
requested, to explain in such statement any mitigating circumstances regarding
the events reported.

         SECTION 11. COVENANT NOT TO SUE, LIMITATION OF ACTIONS AND RELEASE OF
CLAIMS. No legal action shall be brought and no cause of action shall be
asserted by or on behalf of the Company (or any of its subsidiaries) against the
Indemnitee, the spouse, heirs, executors, personal representatives or
administrators of the Indemnitee after the expiration of five years from the
date the Indemnitee ceases (for any reason) to serve as either an officer or a
director of the Company, and any claim or cause of action of the Company (or any
of its subsidiaries) shall be extinguished and deemed released unless asserted
by filing of a legal action within such five year period.

         SECTION 12. INDEMNIFICATION OF INDEMNITEE'S ESTATE; TERM OF AGREEMENT.
Notwithstanding any other provision of this Agreement, and regardless whether
indemnification of the Indemnitee would be permitted and/or required under this
Agreement, if the Indemnitee is deceased, the Company shall indemnify and hold
harmless the Indemnitee's estate, spouse, heirs, administrators, personal
representatives and executors (collectively the "Indemnitee's Estate") against,
and the Company shall assume, any and all claims, damages, expenses, costs
(including attorneys' fees and costs of other professionals), penalties,
judgments, fines and amounts paid in settlement actually incurred by the
Indemnitee or the Indemnitee's Estate in connection with the investigation,
defense, settlement or appeal of any action described in Section 1 or 2 hereof.
Indemnification of the Indemnitee's Estate pursuant to this Section 12 shall be
mandatory and not require a Determination or any other finding that the
Indemnitee's conduct satisfied a particular standard of conduct. This Agreement
shall continue until and terminate upon the later of: (i) ten (10) years after
the date that the Indemnitee shall have ceased to serve as an officer or
director of the Company; or (ii) the entry of a judgment, order or award, not
subject to appeal, in any claim asserted against the Indemnitee subject to this
Agreement.

         SECTION 13. LIMITATION ON INDEMNIFICATION. Notwithstanding any other
provisions of this Agreement, but subject to the provisions of Section 15
hereof, the Indemnitee shall not be entitled to indemnification or advancement
of expenses if (i) a judgment or other final adjudication establishes that the
actions of the Indemnitee, or omissions to act, were material to the cause of
action so adjudicated and constitute: (a) a violation of the criminal law,
unless the Indemnitee had reasonable cause to believe the conduct of the
Indemnitee was lawful or had no reasonable cause to believe the conduct of the
Indemnitee was unlawful; (b) a transaction from which the Indemnitee derived an
improper personal benefit; (c) in the case of a director, a circumstance under
which the liability provisions relating to unlawful distributions under Section
607.0834 of the Florida Act are applicable; or (d) willful misconduct or a

                                       9
<PAGE>

conscious disregard for the best interests of the Company in a proceeding by or
in the right of the Company to procure a judgment in its favor or in a
proceeding by or in the right of a shareholder; or (ii) such indemnification or
advancement of expenses is prohibited by law.

         SECTION 14. MAINTENANCE OF INSURANCE. The Company represents that a
copy of the policies of directors and officers liability insurance that are in
effect are set forth as Exhibit A hereto. The Company hereby agrees that during
the period commencing on the date hereof and ending five years from the date the
Indemnitee ceases to serve the Company, the Company shall purchase and maintain
in effect for the benefit of the Indemnitee such insurance providing coverage at
least as favorable to the Indemnitee as that presently provided, if such
insurance can be purchased for premiums not in excess of 150% of the amount of
the current premiums, adjusted from time to time in accordance with the Consumer
Price Index, or, if such coverage cannot be obtained, the maximum coverage that
can be obtained for 150% of the amount of the current premiums adjusted from
time to time in accordance with the Consumer Price Index.

         SECTION 15. CHANGES IN THE LAW. If any change after the date of this
Agreement in any applicable law, statute or rule or the Company's Articles of
Incorporation expands the power of the Company to indemnify the Indemnitee, such
change shall be within the purview of the Indemnitee's rights and the Company's
obligations under this Agreement. If any change in any applicable law, statute
or rule or the Company's Articles of Incorporation narrows the right of the
Company to indemnify a person such as the Indemnitee, such change, to the extent
not otherwise required by such law, statute or rule or the Company's Articles of
Incorporation to be applied to this Agreement, shall have no effect on this
Agreement or the parties' rights and obligations thereunder.

         SECTION 16. MISCELLANEOUS.

         16.1. Notice Provision. Any notice, payment, demand or communication
required or permitted to be delivered or given by the provisions of this
Agreement shall be deemed to have been effectively delivered or given and
received on the date personally delivered to the respective party to whom it is
directed, or when deposited by registered or certified mail, with postage and
charges prepaid and addressed to the parties at the addresses set forth below
opposite their signatures to this Agreement.

         16.2. Entire Agreement. Except for the Company's Articles of
Incorporation, this Agreement constitutes the entire understanding of the
parties and supersedes all prior understandings, whether written or oral,
between the parties with respect to the subject matter of this Agreement.
Nothing in this Agreement shall be deemed to limit any other indemnification to
which the Indemnitee may be entitled, including under the Company's Articles of
Incorporation, without duplication of payment.

         16.3. Severability of Provisions. If any provision of this Agreement is
held to be illegal, invalid, or unenforceable under present or future laws
effective during the term of this Agreement, such provision shall be fully
severable; this Agreement shall be construed and enforced as if such illegal,
invalid, or unenforceable provision had never comprised a part of this
Agreement; and the remaining provisions of this Agreement shall remain in full
force and effect

                                       10
<PAGE>

and shall not be affected by the illegal, invalid, or unenforceable provision or
by its severance from this Agreement. Furthermore, in lieu of each such illegal,
invalid, or unenforceable provision there shall be added automatically as a part
of this Agreement a provision as similar in terms to such illegal, invalid or
unenforceable provision as may be possible and be legal, valid, and enforceable.

         16.4. Applicable Law. This Agreement shall be governed by and construed
under the laws of the State of Florida.

         16.5. Execution in Counterparts. This Agreement and any amendment may
be executed simultaneously or in counterparts, each of which together shall
constitute one and the same instrument.

         16.6. Cooperation and Intent. The Company shall cooperate in good faith
with the Indemnitee and use its best efforts to ensure that the Indemnitee is
indemnified and/or reimbursed for liabilities described herein to the fullest
extent permitted by law.

         16.7. Amendment. No amendment, modification or alteration of the terms
of this Agreement shall be binding unless in writing, dated subsequent to the
date of this Agreement, and executed by the parties.

         16.8. Binding Effect. The obligations of the Company to the Indemnitee
hereunder shall survive and continue as to the Indemnitee even if the Indemnitee
ceases to be a director, officer, consultant, employee and/or agent of the
Company. Each and all of the covenants, terms and provisions of this Agreement
shall be binding upon and inure to the benefit of the successors to the Company
and, upon the death of the Indemnitee, to the benefit of the estate, heirs,
executors, administrators and personal representatives of the Indemnitee.

         16.9. Nonexclusivity. The rights of indemnification and reimbursement
provided in this Agreement shall be in addition to any rights to which the
Indemnitee may otherwise be entitled by statute, bylaw, agreement, vote of
stockholders or otherwise.

         16.10. Effective Date. The provisions of this Agreement shall cover
claims, actions, suits and proceedings whether now pending or hereafter
commenced and shall be retroactive to cover acts or omissions or alleged acts or
omissions which heretofore have taken place.

                                       11
<PAGE>

       EXECUTED AS OF THE DATE FIRST ABOVE WRITTEN.

ADDRESS:                                          THE COMPANY:

1301 Concord Terrace                              PEDIATRIX MEDICAL GROUP, INC.
Sunrise, Florida 33323-2825

Attention:                                        By: __________________________
                                                  Name: ________________________
                                                  Title: _______________________

ADDRESS:                                          THE INDEMNITEE:

_______________________________                   ______________________________
_______________________________                   Name:
_______________________________

                                       12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00062-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00062-of-00352.parquet"}]]